⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6543221 | 0.69 | — | — | |
| SCHEMBL14364243 | 0.61 | — | — | |
| SCHEMBL3438894 | 0.59 | — | — | |
| SCHEMBL8002188 | 0.57 | — | — | |
| SCHEMBL19772390 | 0.57 | — | — | |
| SCHEMBL666724 | 0.56 | — | — | |
| SCHEMBL21446112 | 0.56 | — | — | |
| SCHEMBL88256 | 0.54 | — | — | |
| SCHEMBL7539505 | 0.54 | — | — | |
| SCHEMBL21122784 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539106-B | Synthetic method of stable isotope labeled taurinamide hydrochloride | 梯尔希（南京）药物研发有限公司 | 2023-05-02 | — | — | CN | disclosed |
| US-20220186222-A1 | LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2022-06-16 | — | — | US | disclosed |
| US-11155527-B2 | Macromolecules comprising triazoles and related compounds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-10-26 | — | — | US | disclosed |
| WO-2021030778-A1 | LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2021-02-18 | — | — | WO | disclosed |
| US-20120101271-A1 | DIAMINE SYNTHESIS VIA CATALYTIC C-H AMINATION OF AZIDES | NATIONAL SCIENCE FOUNDATION | 2012-04-26 | — | — | US | disclosed |
| US-20120101271-A1 | DIAMINE SYNTHESIS VIA CATALYTIC C-H AMINATION OF AZIDES | NATIONAL SCIENCE FOUNDATION | 2012-04-26 | — | — | US | disclosed |
| EP-1756089-B1 | MERCAPTOIMIDAZOLES AS CCR2 RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2008-10-22 | — | — | EP | disclosed |